Overview
Clinical Benefits
- Enhanced cellular energy
- Reduced oxidative stress
- Cardioprotective
- Anti-aging
Administration
Subcutaneous injection
Drug class: mitochondrial peptide
Clinical Dosing
Typical dosage
5mg per dose, 3-5x per week SubQ (range 2.5-10mg)
Starting dose
5mg
Cadence
3-5x per week SubQ
Full titration schedule
| Phase | Dose |
|---|---|
| Weeks 1-2 (Test) | 2.5mg, 3x per week — assess tolerance |
| Weeks 3+ (Maintenance) | 5mg, 3-5x per week SubQ (max 10mg per dose) |
Safety Profile
Side effects
- • Injection site reaction
- • Mild nausea
Contraindications
- • Severe kidney disease
Featured in these stacks
Frequently asked questions
SS-31 (Elamipretide) is most commonly researched for: Enhanced cellular energy, Reduced oxidative stress, Cardioprotective, Anti-aging.
Ready to build a protocol with SS-31 (Elamipretide)?
LIA, our clinical reasoning engine, will build a personalized protocol — dosing, cadence, cycling, and safety checks — tailored to your goals and intake.
You’ll be asked to sign in first. Free tier includes the chat preview.
Information on this page is for educational purposes only and is not medical advice. Peptides should only be used under the supervision of a qualified healthcare provider.